Dry-powder inhalation capsules provide a maior drug development opportunity for pulmonary treatments and systemic applications.
Lonza's Capsugel® Zephyr™ Dry-Powder Inhalation Capsule Portfolio offers the most complete portfolio of DPl capsules with targeted emitted dose that are tailored toward formulation properties and inhalation device. The high-quality customizable capsule solutions based on different polymers and compositions are supported by a wide range of services within Lonza Pharma & Biotech.
To access all of the latest news, white papers, webinars and knowledge center resources, Create An Account. Already have a Capsugel account? Log In
Get access to the latest news, additional whitepapers, webinars and Knowledge Center content. Already have an account? Log In
Please fill in the form below to log in to your Capsugel account. Don’t have an account? Create A Free Account Today!